treatment heart transplant patients powerful immune suppressing drug appears sharply increase risk lethal form blood cell cancer study concludes researchers found 11 patients one hospital treated way quickly developed lymphoma people died the treatment called okt3 antibody attacks variety white blood cells play key role making body reject transplanted organ the new study shows even okt3 prevents rejection doubt benefit comes high price cancer risk